Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Capital Expenditures (2024)

Historic Capital Expenditures for Pyxis Oncology (PYXS) over the last 1 years, with Q1 2024 value amounting to $237000.0.

  • Pyxis Oncology's Capital Expenditures changed N/A to $237000.0 in Q1 2024 from the same period last year, while for Dec 2024 it was $237000.0, marking a year-over-year change of. This contributed to the annual value of $237000.0 for FY2024, which is 9647.64% down from last year.
  • Pyxis Oncology's Capital Expenditures amounted to $237000.0 in Q1 2024.
  • Pyxis Oncology's 5-year Capital Expenditures high stood at $237000.0 for Q1 2024, and its period low was $237000.0 during Q1 2024.